BIOMAT Database Logo BIOMAT Database Logo

A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. 1984

A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres

Hybridoma H129 .19 was derived by fusion between spleen cells of a Lou / Ws1 rat immunized with an Lyt-1+,2- anti-I-Ak cytolytic T lymphocyte (CTL) clone and the nonsecreting myeloma X63-Ag8.653. The monoclonal antibody (mAb) H129 .19 (IgG2a, kappa) was selected for its capacity to inhibit the lytic potential of the immunizing clone. H129 .19 identified a monomorphic determinant on a 55 m.w. murine T cell differentiation antigen, which appeared to be homologous to the human T4 molecule in that: 1) H129 .19 reacted with 80% adult thymocytes, with a subset of splenic T cells, and with the interleukin 2 (IL 2)-producing EL4 thymoma; 2) The mAb bound to and inhibited the IL 2 production and the proliferation of various allo- or soluble antigen-reactive T cell clones that recognized restriction or activating determinants on the I-A or I-E molecules, respectively; 3) H129 .19 did not inhibit the proliferation and/or cytolysis of Lyt-2,3+ T cells specific for class I MHC antigen; and 4) Among six anti-Iak CTL clones examined in this study, the mAb H129 .19 reacted with two I-Ak-specific, Lyt-2,3- clones on which it exerted strong cytolysis inhibiting effect at the effector cell level. By contrast, two other anti-I-Ak and two anti-I-Ek CTL clones were found to express the Lyt-2,3+,T4- cell surface phenotype. The cytolytic potential of the latter clones was not inhibited by anti-Lyt-2,3 mAb. These studies strongly suggest that the mouse T4 molecule facilitates the recognition of class II MHC antigen by most but not all T cells.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008806 Mice, Inbred AKR An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mice, AKR,Mouse, AKR,Mouse, Inbred AKR,AKR Mice,AKR Mice, Inbred,AKR Mouse,AKR Mouse, Inbred,Inbred AKR Mice,Inbred AKR Mouse
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides

Related Publications

A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
January 1987, Immunology today,
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Inhibition of interleukin synthesis and T cell proliferation by a monoclonal anti-Ia antibody.
March 1983, Journal of immunology (Baltimore, Md. : 1950),
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Cytolytic T cell clones against H-21 region Products: an analysis using monoclonal antibodies against Ia, Lyt-2 P94, 180 cell surface antigens.
January 1982, Advances in experimental medicine and biology,
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion.
January 1982, Advances in experimental medicine and biology,
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.
March 1982, Journal of immunology (Baltimore, Md. : 1950),
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies.
January 1984, Journal of immunology (Baltimore, Md. : 1950),
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Mouse monoclonal anti-Ia antibodies recognize cross-reacting determinants expressed on distinct subsets of human Ia-like cell-surface molecules.
May 1983, Molecular immunology,
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Antigen-specific T cell clones restricted to unique F1 major histocompatibility complex determinants. Inhibition of proliferation with monoclonal anti-Ia antibody.
March 1981, The Journal of experimental medicine,
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors.
April 1983, Journal of immunology (Baltimore, Md. : 1950),
A Pierres, and P Naquet, and A Van Agthoven, and F Bekkhoucha, and F Denizot, and Z Mishal, and A M Schmitt-Verhulst, and M Pierres
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.
January 1982, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!